http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%83%86%E5%9B%8A%E7%99%8C-%E5%BD%B1%E5%83%8F%E5%AD%A6%E6%A3%80%E6%9F%A5-PET%2FCT 2026-05-08T15:49:28Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E8%83%86%E5%9B%8A%E7%99%8C-%E5%BD%B1%E5%83%8F%E5%AD%A6%E6%A3%80%E6%9F%A5-PET/CT&diff=1111167&oldid=prev 2024-07-05T14:26:31Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月5日 (五) 14:26的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%83%86%E5%9B%8A%E7%99%8C-%E5%BD%B1%E5%83%8F%E5%AD%A6%E6%A3%80%E6%9F%A5-PET/CT&diff=1003798&oldid=prev 2022-12-06T06:57:54Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2022年12月6日 (二) 06:57的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14" >第14行：</td> <td colspan="2" class="diff-lineno">第14行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===18F-FDG PET/CT在胆囊癌鉴别诊断及分期中的应用价值（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===18F-FDG PET/CT在胆囊癌鉴别诊断及分期中的应用价值（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>以胆囊病灶代谢增高为定性诊断标准,[[PET/CT]]诊断[[胆囊癌]]的灵敏度、特异性和准确性分别为100％(27/27)、44.4％(12/27)和72.2％ (39/54);以SUVmax 6.6为定量诊断标准时的相应值分别为81.5％(22/27)、70.4％ (</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>以胆囊病灶代谢增高为定性诊断标准,[[PET/CT]]诊断[[胆囊癌]]的灵敏度、特异性和准确性分别为100％(27/27)、44.4％(12/27)和72.2％ (39/54);以SUVmax 6.6为定量诊断标准时的相应值分别为81.5％(22/27)、70.4％ (</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"></del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">===双眼弥漫性葡萄膜黑色素细胞增生伴胆囊癌1例（中华医学会文献）===</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">进一步完善[[PET/CT]]确诊&quot;[[胆囊癌]]伴多处淋巴结转移&quot;。</del></div></td><td colspan="2">&#160;</td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%86%E5%9B%8A%E7%99%8C-%E5%BD%B1%E5%83%8F%E5%AD%A6%E6%A3%80%E6%9F%A5-PET/CT&diff=1111166&oldid=prev 2022-09-22T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2022年9月22日 (四) 13:56的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14" >第14行：</td> <td colspan="2" class="diff-lineno">第14行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===18F-FDG PET/CT在胆囊癌鉴别诊断及分期中的应用价值（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===18F-FDG PET/CT在胆囊癌鉴别诊断及分期中的应用价值（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>以胆囊病灶代谢增高为定性诊断标准,[[PET/CT]]诊断[[胆囊癌]]的灵敏度、特异性和准确性分别为100％(27/27)、44.4％(12/27)和72.2％ (39/54);以SUVmax 6.6为定量诊断标准时的相应值分别为81.5％(22/27)、70.4％ (</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>以胆囊病灶代谢增高为定性诊断标准,[[PET/CT]]诊断[[胆囊癌]]的灵敏度、特异性和准确性分别为100％(27/27)、44.4％(12/27)和72.2％ (39/54);以SUVmax 6.6为定量诊断标准时的相应值分别为81.5％(22/27)、70.4％ (</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===双眼弥漫性葡萄膜黑色素细胞增生伴胆囊癌1例（中华医学会文献）===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">进一步完善[[PET/CT]]确诊&quot;[[胆囊癌]]伴多处淋巴结转移&quot;。</ins></div></td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%86%E5%9B%8A%E7%99%8C-%E5%BD%B1%E5%83%8F%E5%AD%A6%E6%A3%80%E6%9F%A5-PET/CT&diff=1003785&oldid=prev 2022-09-22T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[胆囊癌]]，关系：[[影像学检查]] ，尾实体：[[PET/CT]]<br /> <br /> 实体ID:''293039''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===18F-FDG PET/CT对胆囊癌分期、治疗后再分期诊断的价值（中华医学会文献）===<br /> [[胆囊癌]]术后和(或)放化疗后[[PET/CT]]随访17例.<br /> <br /> ===氟代脱氧葡萄糖PET/CT在胆囊癌术前评估中的价值（中华医学会文献）===<br /> [[PET/CT]]对[[胆囊癌]]诊断的灵敏度为90.9%,对淋巴转移诊断的灵敏度和特异度为61.5%和72.3%,对远处转移的诊断灵敏度和特异度为66.7%和91.1%.<br /> <br /> ===18F-FDG PET/CT在胆囊癌鉴别诊断及分期中的应用价值（中华医学会文献）===<br /> 以胆囊病灶代谢增高为定性诊断标准,[[PET/CT]]诊断[[胆囊癌]]的灵敏度、特异性和准确性分别为100％(27/27)、44.4％(12/27)和72.2％ (39/54);以SUVmax 6.6为定量诊断标准时的相应值分别为81.5％(22/27)、70.4％ (</div>

Admin